Minoxidil Vs Exosome Therapy: How They Compare For Hair Loss
Last reviewed on 30 September 2026. We review our treatment guides every six months to keep them accurate.
Key points
They aim to do a similar thing in very different ways. Minoxidil and exosome therapy both stimulate the follicles you still have, rather than treating the hormone (DHT) that causes male pattern loss.
Minoxidil is a cheap, self-applied daily topical. It is a lotion or foam (also available as a tablet) that you use at home, and it is one of the most established hair-loss treatments there is.
Exosome therapy is a newer, in-clinic injection. Exosomes are tiny "messenger" packets usually grown in a laboratory from stem cells, then injected into the scalp, so they do not come from your body and mean clinic visits.
The evidence is worlds apart. Minoxidil has a large, consistent evidence base; exosome therapy is backed mostly by laboratory work, with only early clinical data in people.
Exosomes are promising in theory but not standardised or approved, and are expensive. They carry a richer mix of signals and could in principle be made to a consistent recipe, but products vary widely between clinics, the human data are early, and exosome therapy is far more costly than minoxidil.
Neither adds hair or restores a bald scalp, and neither lowers DHT. Both work on hair that is still there, so neither can regrow a genuinely bald area, and for that a hair transplant is the only option that adds hair.
Both are ongoing commitments. Minoxidil works only while you keep applying it, and exosome therapy needs repeated sessions. Which suits you is best decided with a clinician.
Minoxidil and exosome therapy are both offered to stimulate thinning hair, and they have something in common: both work on the follicles you still have, rather than tackling the hormonal cause of male pattern loss. Beyond that they could hardly be more different. Minoxidil is a cheap, proven treatment you apply yourself; exosome therapy is a newer, expensive, lab-derived injection whose evidence in people is still early.
This guide compares minoxidil and exosome therapy neutrally: what each is, how they differ, how effective they are, what they cost you in commitment and money, who each suits, and how they fit with other treatments. It is general information and not a substitute for advice from a doctor.
The short answer
Minoxidil and exosome therapy both stimulate the follicles you still have without addressing the hormone that causes male pattern loss, so they are close in aim but at opposite ends of the evidence and cost spectrum. Minoxidil is a growth stimulant you apply yourself, a daily topical (or tablet) that is cheap, convenient and backed by a large evidence base. Exosome therapy is an in-clinic injection of lab-grown signalling packets that is promising in theory, with a richer payload, but backed mostly by laboratory studies rather than trials in people, is not standardised or approved, and is far more expensive. If you had to choose one, minoxidil is the cheaper and far better-evidenced option; exosome therapy is the newer, unproven, costly choice, of interest mainly to those drawn to the science or who cannot use minoxidil. Neither, though, can regrow a scalp that is already bald.
What is minoxidil?
Minoxidil is a topical treatment, a lotion or foam applied to the scalp (and now also available as a low-dose tablet), that stimulates the hair follicles. As a comprehensive review of minoxidil explains, it "acts through multiple pathways (vasodilator, anti-inflammatory agent, inducer of the Wnt/beta-catenin signaling pathway, an antiandrogen), and may also affect the length of the anagen and telogen phases", the phases of the hair-growth cycle. Importantly, it is "a prodrug that is metabolized by follicular sulfotransferase", and "those with higher sulfotransferase activity may respond better", which is why some people respond much better than others. The review confirms that "topical minoxidil causes hair regrowth in both frontotemporal and vertex areas". It does not lower DHT, so it stimulates the follicles without treating the hormonal cause. Our guide on minoxidil for hair loss covers it in detail.
What is exosome therapy?
Exosomes are tiny "messenger" packets that cells use to send signals to one another. In hair treatments they are usually grown in a laboratory from stem cells and then injected into the scalp to deliver those signals to the follicles. As a review of exosomes in hair loss explains, they are "nanosized extracellular vesicles rich in proteins, nucleic acids, and lipids" that "modulate the hair follicle microenvironment through activation of Wnt/beta-catenin signaling, promotion of angiogenesis, immunomodulation, and prolongation of the anagen phase", the active growth phase of the hair cycle. In other words, exosomes carry a broader and more varied payload of signals than a single topical drug, which is why there is so much interest in them. The catch is that, unlike minoxidil, they are not made at home, are much newer, and the treatment is not standardised. Our guide on exosome therapy for hair loss explains it further.
Which is more effective for hair loss?
This is where they are least alike: minoxidil has a large, consistent evidence base, while exosome therapy is still mostly experimental. The minoxidil review confirms minoxidil causes regrowth in the areas typically affected by pattern loss, though response varies from person to person, and it is one of the most studied hair-loss treatments there is. Exosome therapy is far earlier: a systematic review of exosome treatment in hair restoration identified only "16 studies (15 preclinical and 1 clinical)", meaning almost all the evidence so far comes from the laboratory rather than from trials in people.
The early human signal for exosomes is encouraging, though. In that single clinical study, the review noted, "topical ADSC-Exo has been tried successfully in 39 androgenetic alopecia patients demonstrating significant increases in hair density and thickness", and "no significant adverse reactions associated with exosome treatment have been reported thus far". Its overall conclusion is the fair summary: "although current clinical evidence supporting the use of exosome treatment is limited, there is a growing body of evidence suggesting its therapeutic potential". So minoxidil is much the more proven of the two, while exosome therapy is promising but not yet backed by strong human trials.
Minoxidil vs exosome therapy: how do they compare?
The two are close in aim but at opposite ends of almost every practical scale:
What they are: minoxidil is a topical lotion or foam (or a low-dose tablet) you apply yourself; exosome therapy is an in-clinic injection of lab-grown signalling packets.
How they work: both stimulate the follicles you still have, and neither lowers the DHT that causes male pattern loss.
Source: minoxidil is a manufactured drug you apply to the scalp; exosomes are usually cell-free and grown in a laboratory from donor stem cells, so they do not come from your body.
Evidence: minoxidil has a large, consistent evidence base; exosome therapy is backed mostly by laboratory work, with only early clinical data in people.
Standardisation and regulation: minoxidil is a well-defined, licensed treatment; exosome products vary widely between suppliers and clinics and are not a standardised or formally approved treatment.
Cost and routine: minoxidil is cheap and self-applied daily; exosome therapy is a much more expensive course of clinic injections with maintenance top-ups.
What neither does: neither adds new hair or restores a bald area, so both are for keeping and supporting the hair you still have rather than replacing hair that is gone.
Which is right for you?
If you want the cheapest, best-evidenced and easiest option, minoxidil is the obvious first step: it is inexpensive, you apply it yourself, and it is one of the most established treatments there is. Exosome therapy is a choice mainly for those who are drawn to the newer science, cannot use minoxidil, or want to add a clinic-based treatment, provided they accept that its human evidence is still early, it is not standardised, and it costs a great deal more. Neither, though, suits someone whose loss is advanced or whose follicles are already gone, because both only work on hair that is still there.
Because exosome products are not standardised and are expensive, it matters even more to choose a reputable clinic and to ask exactly what is being used and what evidence supports it. As with any treatment where the science is still developing, keep your expectations realistic and discuss with a clinician whether it is the right step for your pattern of loss at all, especially when a cheap, proven option like minoxidil exists.
Can they be combined with other treatments?
Yes, and both minoxidil and exosome therapy are usually part of a wider plan rather than a treatment on their own. Because neither addresses the hormonal cause of male pattern loss, they are often used alongside finasteride, the DHT-lowering tablet, which we compare with minoxidil in our guide on finasteride versus minoxidil. Exosome therapy also sits within the wider set of injectable and regenerative options; our guides on minoxidil versus PRP and PRP versus exosomes compare the other treatments in this space, and in practice a cheap, proven base like minoxidil is often the foundation with a clinic treatment added on top.
Neither can restore hair that is already gone. Where loss is more advanced, a hair transplant is a separate option that redistributes your own permanent hair, and a treatment like minoxidil is often used around a transplant to protect and support the result; our guide on hair transplant versus PRP looks at how a regenerative treatment fits around surgery. The key point is that minoxidil and exosome therapy are companions to a treatment plan, not a cure on their own.
The bottom line
Minoxidil and exosome therapy both stimulate the follicles you still have, and neither adds hair, restores a bald area, or lowers the hormone that causes male pattern loss. The difference is stark: minoxidil is a cheap, self-applied daily topical with a large evidence base, while exosome therapy is an expensive, in-clinic, lab-derived injection that is promising in theory but backed mostly by early evidence and is not standardised or approved. Both need to be kept up, and both are best seen as part of a wider plan.
If you had to choose one, minoxidil is the cheaper, far better-evidenced and easier option, while exosome therapy is a newer, unproven and costly choice, of interest mainly to those drawn to the science or who cannot use minoxidil. A clinician can help you decide which, or whether a combination, suits your hair loss, and how it might fit alongside other treatments or a hair transplant.
Frequently asked questions
Is minoxidil or exosome therapy better for hair loss?
On the evidence, minoxidil is much the more proven and is far cheaper, since you apply it yourself at home. Exosome therapy carries a richer mix of growth signals and could in theory be effective, but the human evidence is still early: a systematic review found only one clinical study of exosomes for hair, against years of research on minoxidil. So minoxidil is the better-evidenced, cheaper first choice, while exosome therapy is a newer, expensive option whose case still rests largely on laboratory work.
What is the difference between minoxidil and exosome therapy?
Minoxidil is a topical lotion or foam (or a low-dose tablet) that you apply yourself to stimulate the follicles. Exosome therapy is an in-clinic injection of tiny signalling packets usually grown in a laboratory from donor stem cells, so it is cell-free, does not come from your body, and carries a broader mix of signals. In short, minoxidil is a cheap, proven, self-applied drug, while exosome therapy is a newer, expensive, lab-derived injection; neither lowers the DHT that causes male pattern loss.
Is exosome therapy safe and approved?
Early studies have reported no significant adverse reactions, but the long-term safety data are still limited, and exosome products for hair are not standardised or formally approved as a treatment: what is used varies widely between suppliers and clinics. Minoxidil, by contrast, is a long-established, licensed treatment with a well-known safety profile. With exosomes it is especially important to choose a reputable provider, ask exactly what is being used and what evidence supports it, and treat the therapy as still developing rather than proven.
Do minoxidil or exosome therapy regrow hair on a bald scalp?
No. Both work on follicles that are still present, stimulating them to produce fuller hair, so neither can grow hair where the follicles have already been lost. Neither will restore a genuinely bald or fully receded area; for that, a hair transplant is the only option that adds hair to bare scalp. Minoxidil and exosome therapy are best used earlier, to keep and support the hair you still have, rather than as a cure for baldness.
Get back to Great Hair
in 3 Easy Steps:
01
Arrange Free Consultation
Speak to one of our specialist consultants for expert advice on our range of different hair loss treatments
02
Book Your Procedure
Place a deposit to reserve a time slot at one of the My Hair UK clinics across the UK
03
Attend Your Surgery
Arrive on the day and our specialist surgical team will look after your every need
What People Say About Us
Read our independent My Hair UK Reviews on Reviews.io
The Surgical Team
The surgical team is what makes the difference on the day. The clinics’ five surgeons are all GMC-registered, with a minimum of 1,000 FUE hair transplant procedures each to their name. Between them the team handles complex cases, including Afro-textured and women’s hair transplants, hairline design and lowering, and revision work.
Manchester clinic
• Dr Khawaja Masood Munir: GMC 6122581.
8+ years’ experience, 1,400+ hair transplant surgeries.
• Dr Haider Gillani: GMC 8030796.
1,000+ procedures, with specific expertise in complex cases requiring detailed anatomical understanding.
London (Harrow) clinic
• Dr Mahdi Alosert: GMC 6168297.
20+ years’ clinical experience. Specialist in Afro-Caribbean hair and hairline lowering.
• Dr Shuaib Mir: GMC 7567898.
1,200+ hair transplant cases. BAAPS plastic surgery and RCS anatomy training.
• Dr Zakar Rafiq: GMC 6164032.
MBBS and BSc (Hons) from Imperial College London. Associate Member of the International Society of Hair Restoration Surgery (ISHRS).
You can meet the surgeon who will perform your procedure at your free consultation.